IPIC Message Board - Msg: 5039531

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : IPIC

IPIC 0.0001000

0.0%

Aug 15 3:35 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: muddphudd who wrote (1248)	6/27/1998 5:09:00 PM
From: Cacaito	Read Replies (1) of 1359

I found my source: I bought an Standard and Poor's Stock Report by Fax and it says: " Jan 97, Interneuron announced that its Progenitor subsidiary signed a license agreement with Amgen. The agreement gives Amgen certain exclusive rights for the development and commercialization of products using Progenitor'r leptin receptor technology". Amgen recently had some news about the leptin trial, I think is just in phase I or II, so plenty of time for development of this drug.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next